Molecular basis for lipopolysaccharide mimetic action of Taxol™ and flavolipin

Journal of Endotoxin Research

Volumn 9, Issue 5, 2003, Pages 301-307

  Kawasaki, Kiyoshi ^a   Gomi, Kazunori ^a   Kawai, Yohko ^a   Shiozaki, Masao ^b   Nishijima, Masahiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; FLAVOLIPIN; GLUTAMINE; LIPID; MUTANT PROTEIN; PACLITAXEL; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHRYSEOBACTERIUM MENINGOSEPTICUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; DNA PRIMERS; GLUTAMINE; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PACLITAXEL; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRANSFECTION;

ANIMALIA; BACTERIA (MICROORGANISMS); CHRYSEOBACTERIUM MENINGOSEPTICUM; FLAVOBACTERIUM; MURINAE;

EID: 0141557898     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225002548     Document Type: Article

References (22)

1. Wani MC, Taylor HL, Wall ME, Coggon P, McPhali AT. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 1971; 93: 2325-2327.
2. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by Taxol. Nature 1979; 277: 665-667.
3. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561-1565.
4. Raetz CRH. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-170.
5. Ding AH, Porteu F, Sanchez E, Nathan CF. Shared actions of endotoxin and Taxol on TNF receptors and TNF release. Science 1990; 248: 370-372.
6. Kirikae T, Ojima I, Fuero-Oderda C et al. Structural significance of the acyl group at the C-10 position and the A ring of the taxane core of paclitaxel for inducing nitric oxide and tumor necrosis factor production by murine macrophages. FEBS Lett 2000; 478: 221-226.
7. Perera P-Y, Qureshi N, Vogel SN. Paclitaxel (Taxol)-induced NF-κB translocation in murine macrophages. Infect Immun 1996; 64: 878-884.
8. Allen JN, Moore SA, Wewers AM. Taxol enhances but does not induce interleukin-1β and tumor necrosis factor-α production. J Lab Clin Med 1993; 122: 374-381.
9. Lee L-F, Schuerer-Maly C-C, Lofquist AK et al. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res 1996; 56: 1303-1308.
10. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. Mouse Toll like receptor 4/MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 2000; 275: 2251-2254.
11. Kawai Y, Yano I, Kaneda K. Various kinds of lipoamino acids including a novel serine-containing lipid in an opportunistic pathogen Flavobacterium. Their structures and biological activities on erythrocytes. Eur J Biochem 1988; 171: 73-80.
12. Shiozaki M, Deguchi N, Mochizuki T et al. Revised structure and synthesis of flavolipin. Tetrahedron 1998; 54: 11861-11876.
13. Kawai Y, Yano I. Ornithine-containing lipid of Bordetella pertussis, a new type of hemagglutinin. Eur J Biochem 1983; 136: 531-538.
14. Kawai Y, Yano I. Kaneda K, Yabuuchi E. Ornithine-containing lipids of some Pseudomonas species. Eur J Biochem 1988; 175: 633-641.
15. Kawai Y, Nakagawa Y, Matuyama T et al. A typical bacterial ornithine-containing lipid N′-(D)-[3-(hexadecanoyloxy)hexadecanoyl]-ornithine is a strong stimulant for macrophages and a useful adjuvant. FEMS Immunol Med Microbiol 1999; 23: 67-73.
16. Kawazoe R, Okuyama H, Reichardt W, Sasaki S. Phospholipids and a novel glycine-containing lipoamino acid in Cytophaga johnsonae Stanier strain C21. J Bacteriol 1991; 173: 5470-5475.
17. Uchida I, Yoshida K, Kawai Y et al. Studies on WB-3559 A, B, C and D, new potent fibrinolytic agents. II. Structure elucidation and synthesis. J Antibiot 1985; 38: 1476-1486.
18. Kawai Y, Akagawa K. Macrophage activation by an ornithine-containing lipid or a serine-containing lipid. Infect Immun 1989; 57: 2086-2091.
19. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acid Res 1990; 18: 5322.
20. Silver J, Limjoco T, Feinstone S. Site-specific mutagenesis using the polymerase chain reaction. In: Innis MA, Gelfand DH, Sninsky JJ. (eds) PCR Strategies. San Diego, CA: Academic Press, 1995; 179-188.
21. Akashi S, Shimazu R, Ogata H et al. Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000; 164: 3471-3475.
22. Perera P-Y, Vogel SN, Detore GR, Haziot A, Goyert SM. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or Taxol. J Immunol 1997; 158: 4422-4429.